Internal Server Error

About Sixty4 Ventures

Sixty4 Ventures is a venture capital firm located in Vancouver, Canada. It primarily invests in Canada based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and FinTech. Overall, Sixty4 Ventures portfolio has seen 11 IPOs and 5 acquisitions including key companies like WELL Health Technologies Corp, ESSA Pharma and Versapay.
Key Metrics

Sixty4 Ventures' List of Top Investments

Sixty4 Ventures has a portfolio of 16 companies. Their most notable investments include WELL Health Technologies Corp and ESSA Pharma.Their portfolio spans across Canada and United States. They have invested in Enterprise Applications, HealthTech, FinTech and 10 other sectors. Here is the list of top investments by Sixty4 Ventures:
Provider of EMR and virtual care tools for providers. The company offers virtual care and digital patient engagement capabilities, along with Electronic Medical Records (EMR), Revenue Cycle Management, and cybersecurity & data protection software for medical practitioners.

Key facts about WELL Health Technologies Corp

  • Founded Year: 2010
  • Location: Vancouver (Canada)
  • Annual Revenue: $100M - $500M as on Dec 31, 2020
  • Stage: Public
  • Employee Count: 440 as on Aug 31, 2026
  • Investors: JPMorgan Chase, Scotiabank and 4 Others
  • Latest Funding Round: Post IPO, Jan 31, 2024, $*****
  • Highlight: Public
Developer of small molecule drugs for the treatment of cancer. The company is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR), which has been indicated in the growth and survival of most prostate cancer. The product pipeline includes EPI-7386 for metastatic Castration-resistant Prostate cancer (CRPC). and it is also developing drugs for breasts cancer.

Key facts about ESSA Pharma

  • Founded Year: 2009
  • Location: Vancouver (Canada)
  • Stage: Acquired
  • Total Funding till date: $16.4M
  • Employee Count: 15 as on Sep 30, 2026
  • Investors: BVF Partners, BB Biotech and 9 Others
  • Latest Funding Round: Post IPO, Jan 12, 2021, $*****
  • Highlight: Acquired
Provider of accounts receivable automation software and integrated payment solutions. The company offers digital invoicing, cash application, collections management, and reporting and reconciliation tools. B2B payment services include ACH, credit cards, and ERP options. The platform integrates with ERP systems via open APIs or flat files.

Key facts about Versapay

Provider of radiant energy vacuum drying devices for food businesses. The company offers vacuum drying devices with pressure and microwave energy features for drying process. It offers moisture drying devices including freeze-drying or air drying. The company also caters to the pharmaceuticals, cannabis, and hemp industries.

Key facts about Enwave

Provider of digital asset management software for enterprise content organization. This platform centralizes digital files, allowing teams to store, search, and share assets through artificial intelligence tagging and automated metadata. It includes security features, identity management controls, and integration tools to connect with various creative applications and internal systems. Organizations use the software to maintain brand consistency, manage version control, and streamline workflows across internal departments and external partners. The infrastructure supports large-scale libraries with scalable storage, reporting capabilities, and auditing tools to ensure compliance and governance.

Key facts about MediaValet

IPOs and Publicly Listed companies in Sixty4 Ventures' Portfolio

11 of Sixty4 Ventures' portfolio companies have become public. CEMATRIX got listed on the Toronto Stock Exchange (TSX), in Jul 2024 at marketcap of $1.55M and StorageVault Canada got listed on the Toronto Stock Exchange (TSX).
Here are Sixty4 Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jul 16, 2024
-
-
3195
Jan 26, 2022
-
-
1877
Dec 09, 2020
-
-
6390
Apr 01, 2016
-
-
3733
Apr 24, 2015
-
-
2681

Acquired companies in Sixty4 Ventures' Portfolio

5 companies from Sixty4 Ventures' portfolio have been acquired. The most recent acquisition was ESSA Pharma in Jul 2025 by Alexis Bio for $*****.
Here are Sixty4 Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jul 14, 2025
-
-
1974
Jan 18, 2025
-
-
7078
Apr 02, 2024
-
-
6087
Dec 08, 2021
-
-
4780
Dec 13, 2019
-
-
5855

FAQs about Sixty4 Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford